Preparing the gilt: Health aspects
Joan Aparicio and Lluís Ferrer share their experience on how to prepare the replacement animals with Joan Wennberg.
Page 9 of articles about vaccine
Three leading animal health companies join hands to launch world-class vaccine joint venture targeting foot-and-mouth disease in China
Boehringer Ingelheim, KMOH, and ZNWT establish a vaccine joint venture targeting foot-and-mouth disease control and prevention in China.
Mycoplasma hyopneumoniae vaccination at or shortly before weaning
This study assessed the efficacy of two different Mycoplasma hyopneumoniae vaccination programmes in relation to the time of weaning.
VEPURED®, the new purified vaccine against edema disease from Hipra
On 19th October last, Hipra launched the new VEPURED® vaccine against edema disease. The event, which took place in Germany, was attended by over 200 specialist veterinarians from Europe and Russia.
Effect of vaccination against sub-clinical PCV2 infection in a high-health finishing pig herd
The purpose of the study was to evaluate the effect of vaccination against PCV2 in a sub-clinically infected, high-health finishing herd in terms of viral load in serum, feed conversion ratio and antimicrobial treatments.
Probiotics, prebiotics and colostrum as feed additives for piglets under vaccination against PRRSV
The development of piglet immune system under vaccination against PRRSV it is not improved by the use of probiotics and prebiotics or colostrum.
Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China
Here we analyzed the molecular variations and antigenic differences among the C-strain-based commercial vaccines of different origins from different manufacturers in China, and reevaluated the vaccines against the emerging subgenotype 2.1d strain of CSFV.
Introduction of replacement gilts to PRRS-positive sow herds
A study was performed including 69 PRRS-positive sow herds with the aim of comparing the use of PRRSV MLV and quarantine facilities with the PRRSV status of replacement gilts at first insemination.
Importance of Hepatitis E virus in pigs
As the risk of HEV exposure appears to rise in the human population an opportunity for production and certification of HEV free meat products, especially pork, is emerging.
Adenovirus-vectored vaccine confers protection against FMDV O1 Manisa in swine
Recombinant Ad5-O1Man is an effective, safe and cross-reacting vaccine that could potentially be used preventively and in outbreak situations, to control FMDV O Mya-98 lineage in swine.
The impact of intensive vaccination on PCV2 epidemiology
The decrease in PCV2a and PCV2b genotypes over time and the increase in PCV2d in 2012 may be due more to other, unknown, factors than to immunological selection resulting from PCV2a-based vaccination.
No clear effect of initiating vaccination on the amounts of prescribed antimicrobials
We studied the change in amounts of antimicrobials prescribed for weaners and finishers in Danish herds duriong 2007-2013 following initiation of vaccination against five common endemic infections.
PRRSV control using vaccination and optimized management: three case studies
Although the use of vaccination was effective in stabilizing the sows, the results of these case studies emphasized that elimination of PRRSV from the nursery can only be accomplished if vaccination and partial depopulation/ disinfection are supported by strict implementation of all recommended management procedures, including AI/AO.
Update on novel experimental pig vaccine approaches
Dr. Tanja Opriessnig, The Roslin Institute, University of Edinburgh and Iowa State University, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.
Prevention of the disease caused by Actinobacillus pleuropneumoniae (App)
This article explains the main preventive measures against App, focusing on the use of antimicrobials and vaccines.
Impact of maternally derived immunity on piglets’ immune response and protection against PCV2 after vaccination at different age
This study was aimed at evaluating the clinical protection, the level of Porcine circovirus type 2 (PCV2) viremia and the immune response (antibodies and IFN-γ secreting cells (SC)) in piglets derived from PCV2 vaccinated sows and themselves vaccinated against PCV2 at different age, namely at 4, 6 and 8 weeks.